ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

Torsten Kucharzik; Pierre Ellul; Thomas Greuter; J.‐F. Rahier; Bram Verstockt; Cândida Abreu; Andreia Albuquerque; Mariangela Allocca; María Esteve; Francis A. Farraye; Hannah Gordon; Konstantinos Κarmiris; Uri Kopylov; Julien Kirchgesner; Eithne MacMahon; Fernando Magro; Christian Maaser; Lissy de Ridder; Carlos Taxonera; Murat Törüner; Lydjie Tremblay; Michael Scharl; N. Viget; Yamile Zabana; S Vavricka

doi:10.1093/ecco-jcc/jjab052

ECCO Guidelines on the Prevention, Diagnosis, and Management of Infections in Inflammatory Bowel Disease

Рекомендации ECCO по профилактике, диагностике и лечению инфекций при воспалительных заболеваниях кишечника

Torsten Kucharzik, Pierre Ellul, Thomas Greuter, J.‐F. Rahier, Bram Verstockt, Cândida Abreu, Andreia Albuquerque, Mariangela Allocca, María Esteve, Francis A. Farraye, Hannah Gordon, Konstantinos Κarmiris, Uri Kopylov, Julien Kirchgesner, Eithne MacMahon, Fernando Magro, Christian Maaser, Lissy de Ridder, Carlos Taxonera, Murat Törüner, Lydjie Tremblay, Michael Scharl, N. Viget, Yamile Zabana, S Vavricka

2021-03-13

SCID: 54.1/aynekxht Discuss with AI

JAK inhibitorsbiologic agentsimmunosuppressive agentsinflammatory bowel diseaseopportunistic infections

Abstract (AI)

INTRODUCTION : The introduction and broad use of new immunosuppressive agents, including biologic agents and JAK inhibitors, have revolutionised treatment of inflammatory bowel disease [IBD] in recent decades. With such immunosuppression, the potential for opportunistic infection is a key safety concern. [...]

Key Findings

Infection prevention and safety management are essential considerations when using immunosuppressive therapies for IBD.

The guidelines address prevention, diagnosis, and management of infections in patients with inflammatory bowel disease.

The widespread use of biologic agents and JAK inhibitors has transformed IBD treatment but increases concerns about opportunistic infections under immunosuppression.

Research Object

infections in patients with inflammatory bowel disease receiving immunosuppressive therapy

Research Subject

prevention, diagnosis, and management of opportunistic infections and infection-related safety risks

Publication Details

DOI

10.1093/ecco-jcc/jjab052

Publication Date

2021-03-13

Journal

Publisher

ISSN

Cited by

481

Open access PDF

https://academic.oup.com/ecco-jcc/article-pdf/1…

Access Type

Author Information

Authors

Torsten Kucharzik

Pierre Ellul

Thomas Greuter

J.‐F. Rahier

Bram Verstockt

Cândida Abreu

Andreia Albuquerque

Mariangela Allocca

María Esteve

Francis A. Farraye

Hannah Gordon

Konstantinos Κarmiris

Uri Kopylov

Julien Kirchgesner

Eithne MacMahon

Fernando Magro

Christian Maaser

Lissy de Ridder

Carlos Taxonera

Murat Törüner

Lydjie Tremblay

Michael Scharl

N. Viget

Yamile Zabana

S Vavricka

Download PDF

Make a presentation